The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Retinoic Acid Receptor Alpha - Drugs In Development, 2021
US$ 3,500.00
Retinoic Acid Receptor Alpha - Drugs In Development, 2021 SUMMARY Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) pipeline Target constitutes...
August 2021
76 pages
Retinoic Acid Receptor Gamma - Drugs In Development, 2021
US$ 3,500.00
Retinoic Acid Receptor Gamma - Drugs In Development, 2021 SUMMARY Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Retinoic acid receptor ga...
August 2021
88 pages
Asthma (Respiratory) - Drugs In Development, 2021
US$ 2,500.00
Asthma (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Drugs In Development, 2021, provides an overview...
August 2021
931 pages
Bone Metastasis (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Bone Metastasis (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bone Metastasis - Drugs In Development, 2021, provid...
August 2021
106 pages
Bronchiectasis (Respiratory) - Drugs In Development, 2021
US$ 2,000.00
Bronchiectasis (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchiectasis - Drugs In Development, 2021, provi...
August 2021
123 pages
Cataract (Ophthalmology) - Drugs In Development, 2021
US$ 2,000.00
Cataract (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cataract - Drugs In Development, 2021, provides an ove...
August 2021
46 pages
Gastric Cancer (Oncology) - Drugs In Development, 2021
US$ 2,500.00
Gastric Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer - Drugs In Development, 2021, provides...
August 2021
3373 pages
Hairy Cell Leukemia (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Hairy Cell Leukemia (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hairy Cell Leukemia - Drugs In Development, 2021...
August 2021
194 pages
Head And Neck Cancer (Oncology) - Drugs In Development, 2021
US$ 2,500.00
Head And Neck Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Drugs In Development, 20...
August 2021
4327 pages
Keratitis (Ophthalmology) - Drugs In Development, 2021
US$ 2,000.00
Keratitis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Keratitis - Drugs In Development, 2021, provides an o...
August 2021
105 pages
Optic Neuritis (Ophthalmology) - Drugs In Development, 2021
US$ 2,000.00
Optic Neuritis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Optic Neuritis - Drugs In Development, 2021, pro...
August 2021
57 pages
Osteoporosis (Musculoskeletal) - Drugs In Development, 2021
US$ 2,500.00
Osteoporosis (Musculoskeletal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis - Drugs In Development, 2021, provi...
August 2021
401 pages
Pheochromocytoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Pheochromocytoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pheochromocytoma - Drugs In Development, 2021, prov...
August 2021
179 pages
Rabies (Infectious Disease) - Drugs In Development, 2021
US$ 2,000.00
Rabies (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rabies - Drugs In Development, 2021, provides an ov...
August 2021
108 pages
Retinoblastoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Retinoblastoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinoblastoma - Drugs In Development, 2021, provides...
August 2021
84 pages
Stroke (Cardiovascular) - Drugs In Development, 2021
US$ 2,500.00
Stroke (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Drugs In Development, 2021, provides an overvi...
August 2021
862 pages
Ureter Cancer (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Ureter Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ureter Cancer - Drugs In Development, 2021, provides a...
August 2021
516 pages
Global Penicillin Drug Market by Product (Bulk and Dosage), Type (Aminopenicillin, Antipseudomonal Penicillin, Beta-lactamase Inhibitor, Natural Penicillin, and Penicillinase-resistant Penicillin), Manufacturing Process (Synthetic Process, Natural Process, and Semisynthetic Process), Mode of Delivery (Oral, Intramuscular, and Intravenous), and End User (Hospitals, Clinics, Research Institutes, and Others), Regional Forecasts 2021-2027
US$ 3,750.00
Global Penicillin Drug Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2021-2027. Penicillin is...
August 2021
200 pages
Global Vitamin Deficiency Treatment Market Size study, by Product (OTC Multivitamin Therapies, Single Vitamin Therapies, Vitamin A Supplements, Vitamin B Complex Supplements, Vitamin D Supplements and Others), End User (Pharmacy and Drugstores, Hospital Pharmacy, Online Drug Stores or Email Prescription Stores, Hypermarkets and Supermarkets), and Regional Forecasts 2021-2027
US$ 3,750.00
Global Vitamin Deficiency Treatment Market is valued approximately USD xx billion in 2020 and is anticipated to grow with a healthy growth rate of more than xx % over the forecast period 2021-2027. Vi...
August 2021
200 pages
5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021
US$ 3,500.00
5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021'; 5-Hydroxytryptamine Recept...
July 2021
63 pages
